Hasil Pencarian (2)
Onvansertib
DB15110
small molecule | CAS: 1034616-18-6
Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
Kategori:
Enzyme InhibitorsHeterocyclic Compounds, Fused-RingProtein Kinase Inhibitors
Target Protein:
Serine/threonine-protein kinase PLK1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik
-